Emerging Technologies: Prostate Cancer Imaging & Management Update (2019)

Emerging Technologies: Prostate Cancer Imaging & Management Update (2019) is organized by Radiological Society of North America (RSNA).

Start Date: 3/18/2020
End Date for CME Eligibility/Online Expiration Date: 3/17/2023

Description:
Refresher Courses are sessions captured at past RSNA Annual Meetings focusing on themes of health care reform, payment models, research and innovation, patient-centered radiology, and advances in the different imaging modalities. Refresher Courses are targeted at diagnostic, interventional, and oncologic radiologists and are designed to improve knowledge and competence in responding to the challenges and advancements in the field of radiology. Most courses include an audio-visual presentation, as well as a corresponding transcript.

Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:
• Genitourinary Radiology
• Magnetic Resonance Imaging
• Molecular Imaging
• Nuclear Medicine

Learning Objectives:
• Identify current issues in prostate cancer relevant to imaging.
• Review the role of emerging technologies in the imaging and management of prostate cancer.
• Describe the impact of new screening guidelines on the imaging of prostate cancer.
• Recognize the issues facing clinicians treating prostate cancer.
• Identify the current status and uses of multi-parametric MRI.
• Review the role of MRI in the assessment of prostate cancer aggressiveness and tumor heterogeneity.
• Review the role of computer-aided diagnosis systems in the evaluation of prostate cancer aggressiveness and tumor heterogeneity.
• Compare and contrast the imaging characteristics of present and emerging molecular imaging agents for prostate cancer.
• Describe how emerging molecular imaging agents for prostate cancer are being integrated into clinical practice.
• Compare PET agents targeting the prostate-specific membrane antigen (PSMA) with respect to a new structured reporting system proposed to enhance clinical management.
• Describe the basic principles and techniques used in hyperpolarized carbon-13 MRI.
• Recognize the cellular metabolic reprogramming that occurs in prostate cancer.
• Demonstrate the changes in pyruvate to lactate conversion that are observed in prostate cancer and differences in cancer aggressiveness and response to therapy.